CA-64-LT35_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, N-(3-bromo-4-methylphenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine, VEGFR-2 (FLK-1/KDR) Inhibitors;Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways targeting KDR (Novartis, 6918616)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/6918616
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the CA-64-LT35_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FKBP1A FK506 binding protein 1A, 12kDa 2.39958
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 0.760225
MYL12B myosin, light chain 12B, regulatory 0.523648
C19ORF33 chromosome 19 open reading frame 33 0.438837
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.287518
RPL37A ribosomal protein L37a 0.287518
PRRX2 paired related homeobox 2 0.274968
COX8A cytochrome c oxidase subunit VIIIA (ubiquitous) 0.256968
IL4I1 interleukin 4 induced 1 0.230929
EIF5AL1 eukaryotic translation initiation factor 5A-like 1 0.213804
ATP5MC1 ATP synthase membrane subunit c locus 1 0.213804

decreased expression

Symbol Name Standardized Value
NMT2 N-myristoyltransferase 2 -0.334921
RING1 ring finger protein 1 -0.303343
ZMAT5 zinc finger, matrin-type 5 -0.213804